STANDARD BIOTOOLS INC. 8-K

What Happened

• Standard BioTools Inc. announced financial results for the three months and fiscal year ended December 31, 2025 via a press release dated February 24, 2026. The company filed Form 8-K reporting these results (Item 2.02) and made a Regulation FD disclosure (Item 7.01).
• The press release is attached to the filing as Exhibit 99.1. The filing incorporates the press release information by reference into the Form 8-K, except for the sections titled “Full Year 2026 Revenue Outlook” and “About Standard BioTools Inc.” The forward-looking statement disclaimer in the release is incorporated by reference.

Key Details

• Press release date: February 24, 2026.
• Reporting periods: three months and fiscal year ended December 31, 2025.
• Exhibit included: Press release (Exhibit 99.1) and interactive XBRL cover page (Exhibit 104).
• Incorporated content excludes the “Full Year 2026 Revenue Outlook” and company description headings (these were not incorporated).

Why It Matters

• Investors should read the attached press release for specific financial metrics (revenue, earnings, margins) and management commentary on 2025 performance. The 8-K confirms the company publicly disclosed its quarterly and full-year results and made those results available to the market under Regulation FD.
• Note that the filing does not incorporate the “Full Year 2026 Revenue Outlook” text; any 2026 guidance language and the forward-looking disclaimer should be reviewed in the press release itself before making investment decisions.